| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/10/2007 | US7241766 Methods of using phenolic guanidine sodium channel blockers |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241761 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups |
| 07/10/2007 | US7241760 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241756 Containing 5-[4-[2[(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a salt for treating non-insulin dependent diabetes with improved blood glucose regulation without introducing unacceptable side-effects |
| 07/10/2007 | US7241751 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses |
| 07/10/2007 | US7241749 2 Alpha-methyl-19,26,27-trinor-(20S)-1-alpha-hydroxyvitamin D3 and protected derivatives; arrests the proliferation of undifferentiated cells and induces their differentiation to monocytes; treating cancer, skin disorders, autoimmune disorders, inflammatory conditions, obesity and renal osteodystrophy |
| 07/10/2007 | US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives |
| 07/10/2007 | CA2549561C 36- derivatives of rifamycins |
| 07/10/2007 | CA2380072C Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/10/2007 | CA2370823C Metal catalysts and methods for making and using same |
| 07/10/2007 | CA2301852C Angiogenesis promoters and angiogenesis potentiators |
| 07/05/2007 | WO2007076474A1 Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases |
| 07/05/2007 | WO2007076473A2 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases |
| 07/05/2007 | WO2007076431A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | WO2007076247A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 07/05/2007 | WO2007076104A1 Vanilloid receptor ligands and their use in treatments |
| 07/05/2007 | WO2007076092A2 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases |
| 07/05/2007 | WO2007075688A2 Substituted aniline derivatives useful as histamine h3 antagonists |
| 07/05/2007 | WO2007075650A2 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders |
| 07/05/2007 | WO2007074856A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | WO2007074786A1 Probe for diagnosis of conformational disease |
| 07/05/2007 | WO2007074753A1 Pharmaceutical comprising substituted urea derivative |
| 07/05/2007 | WO2007074099A1 A process for the preparation of the (s)-enantiomer of omeprazole |
| 07/05/2007 | WO2007073934A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 07/05/2007 | WO2007058583A3 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007053765A3 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 07/05/2007 | WO2007046867A3 Piperidine derivatives and their uses as therapeutic agents |
| 07/05/2007 | WO2007038138A3 Amido compounds and their use as pharmaceuticals |
| 07/05/2007 | WO2007026254A3 Benzodiazepine derivatives , their preparation and the therapeutic use thereof |
| 07/05/2007 | WO2006133381A3 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,4,6-trichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
| 07/05/2007 | WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 07/05/2007 | WO2006055752A3 INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME |
| 07/05/2007 | US20070155967 Process for producing piperidine-2,6 diones heterocyclically substituted in the 3-position |
| 07/05/2007 | US20070155966 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV) |
| 07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 07/05/2007 | US20070155818 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist |
| 07/05/2007 | US20070155817 Indolylmaleimide derivatives |
| 07/05/2007 | US20070155803 Protease inhibitors |
| 07/05/2007 | US20070155796 Crystals of benzimidazole compounds |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155793 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 07/05/2007 | US20070155792 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155785 Hydroxamic acid compounds and methods of use thereof |
| 07/05/2007 | US20070155784 Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 07/05/2007 | US20070155783 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto |
| 07/05/2007 | US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 07/05/2007 | US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors |
| 07/05/2007 | US20070155744 N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors |
| 07/05/2007 | US20070155743 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders |
| 07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155728 Substituted Heterocyclic Compounds |
| 07/05/2007 | US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist |
| 07/05/2007 | US20070155722 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| 07/05/2007 | US20070155721 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide |
| 07/05/2007 | US20070155719 Platelet ADP receptor inhibitors |
| 07/05/2007 | US20070155712 Compounds for the inhibition of angiogenesis and use thereof |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070151046 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds |
| 07/05/2007 | DE102005063066A1 2-[Pyrazolyl-methan-sulfonyl])-pyridin-N-oxid-Derivate und 2-[Pyrazlyl-methan-sulfinyl])-pyridin-N-oxid-Derivate, Verfahren zu deren Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren 2- [pyrazolyl-methane-sulfonyl]) - pyridin-N-oxide derivatives and 2- [Pyrazlyl-methane-sulfinyl]) - pyridin-N-oxide-derivatives, processes for their preparation and use as herbicides and plant growth regulators |
| 07/05/2007 | DE102005062987A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments |
| 07/05/2007 | CA2753405A1 Nitrogen-containing bicyclic heteroaryl compounds and methods of use |
| 07/05/2007 | CA2634847A1 Substituted aniline derivatives useful as histamine h3 antagonists |
| 07/05/2007 | CA2634833A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | CA2634794A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | CA2634250A1 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 07/05/2007 | CA2634232A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | CA2634084A1 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders |
| 07/05/2007 | CA2633992A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 07/05/2007 | CA2633653A1 Heterocyclic derivatives as modulators of ion channels |
| 07/05/2007 | CA2631777A1 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor |
| 07/05/2007 | CA2631459A1 A process for the preparation of the (s)-enantiomer of omeprazole |
| 07/04/2007 | EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2007 | EP1803719A1 1,5-diheterocycle-1h-triazole derivative |
| 07/04/2007 | EP1803718A1 4-Tetrazolyl-4-phenylpiperidine derivatives for treating pain |
| 07/04/2007 | EP1803710A1 Pyrimidine derivative condensed with non-aromatic ring |
| 07/04/2007 | EP1803709A1 Proton pump inhibitors |
| 07/04/2007 | EP1802623A1 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 07/04/2007 | EP1802615A1 Phosphodiesterase 4 inhibitors |
| 07/04/2007 | EP1802611A2 Heterocyclic diamide insecticidal agents |
| 07/04/2007 | EP1802608A1 Quinazoline derivatives for use against cancer |
| 07/04/2007 | EP1802607A2 Salt and crystalline forms thereof of a drug |
| 07/04/2007 | EP1802606A2 Compositions and their use as anti-tumor agents |
| 07/04/2007 | EP1802605A1 Imidazole derivatives as vanilloid receptor ligands |
| 07/04/2007 | EP1802604A1 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 07/04/2007 | EP1802603A1 Quinoline derivatives |
| 07/04/2007 | EP1802602A1 Substituted dipiperdine ccr2 antagonists |
| 07/04/2007 | EP1802601A1 Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity |
| 07/04/2007 | EP1802591A1 Quinazoline derivatives |
| 07/04/2007 | EP1802590A1 Substituted n-alkylpyrimidinones |
| 07/04/2007 | EP1802588A1 Substituted amino-pyrimidones and uses thereof |